Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine on Glottic Aperture Angle
NCT04545099Unknown
- Sponsor
- Yonsei University
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Yonsei University. Primary endpoints: Angle of vocal folds after administration of sugammadex or neostigmine and Degree of change in angle of vocal folds before and after administration of sugammadex or neostigmine. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT04545099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545099.